CTLA4 and neoplasm: Studies have shown that Tregs constitutively express CTLA-4 to exert its immunosuppressive, and Treg-specific CTLA-4 deficiency has been shown to interfere with immune self-tolerance and suppressive function of Treg in vivo and promote tumor immunity [48,49].